Extracellular matrix proteins: A positive feedback loop in lung fibrosis?

Matrix Biology

Volumn 34, Issue , 2014, Pages 170-178

  Blaauboer, Marjolein E ^a,b   Boeijen, Fee R ^a   Emson, Claire L ^c   Turner, Scott M ^c   Zandieh Doulabi, Behrouz ^a   Hanemaaijer, Roeland ^b   Smit, Theo H ^d   Stoop, Reinout ^b   Everts, Vincent ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b TNO   (Netherlands)

^c KINEMED INC   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Elastin; Extracellular matrix; Lung fibrosis; Myofibroblast differentiation; Tenascin C; Type V collagen

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; DEUTERIUM; ELASTIN; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; TYPE V COLLAGEN; UNCLASSIFIED DRUG; BLEOMYCIN; COLLAGEN TYPE 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BLOOD VESSEL WALL; BRONCHIOLE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG FIBROSIS; LUNG PARENCHYMA; MICROARRAY ANALYSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE; TISSUE SECTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOLOGY; TOXICITY;

ANIMALIA; MUS;

ANIMALS; BLEOMYCIN; CELL DIFFERENTIATION; COLLAGEN TYPE V; ELASTIN; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LUNG; MICE; MYOFIBROBLASTS; PULMONARY FIBROSIS; TENASCIN;

EID: 84900343637     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.11.002     Document Type: Article

References (39)

1. Bax D.V., Rodgers U.R., Bilek M.M.M., Weiss A.S. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J. Biol. Chem. 2009, 284:28616-28623.
2. Birk D.E. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001, 32:223-237.
3. Blaauboer M.E., Smit T.H., Hanemaaijer R., Stoop R., Everts V. Cyclic mechanical stretch reduces myofibroblast differentiation of primary lung fibroblasts. Biochem. Biophys. Res. Commun. 2011, 404:23-27.
4. Blaauboer M.E., Emson C.L., Verschuren L., van Erk M., Turner S.M., Everts V., Hanemaaijer R., Stoop R. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Matrix Biol. 2013.
5. Booth A.J., Hadley R., Cornett A.M., Dreffs A.A., Matthes S.A., Tsui J.L., Weiss K., Horowitz J.C., Fiore V.F., Barker T.H., Moore B.B., Martinez F.J., Niklason L.E., White E.S. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am. J. Respir. Crit. Care Med. 2012, 186:866-876.
6. Braun R.K., Martin A., Shah S., Iwashima M., Medina M., Byrne K., Sethupathi P., Wigfield C.H., Brand D.D., Love R.B. Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V. J. Heart Lung Transplant. 2010, 29:873-880.
7. Broekelmann T.J., Kozel B.a, Ishibashi H., Werneck C.C., Keeley F.W., Zhang L., Mecham R.P. Tropoelastin interacts with cell-surface glycosaminoglycans via its COOH-terminal domain. J. Biol. Chem. 2005, 280:40939-40947.
8. Cha S.I., Groshong S.D., Frankel S.K., Edelman B.L., Cosgrove G.P., Terry-Powers J.L., Remigio L.K., Curran-Everett D., Brown K.K., Cool C.D., Riches D.W. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2010, 42:140-148.
9. Chua F., Gauldie J., Laurent G.J. Pulmonary fibrosis: searching for model answers. Am. J. Respir. Cell Mol. Biol. 2005, 33:9-13.
10. Collins J.F., McCullough B., Coalson J.J., Johanson W.G. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. II. Further studies on connective tissue changes. Am. Rev. Respir. Dis. 1981, 123:305-312.
11. Degryse A.L., Lawson W.E. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011, 341:444-449.
12. Dolhnikoff M., Mauad T., Ludwig M.S. Extracellular matrix and oscillatory mechanics of rat lung parenchyma in bleomycin-induced fibrosis. Am. J. Respir. Crit. Care Med. 1999, 160:1750-1757.
13. Duca L., Blanchevoye C., Cantarelli B., Ghoneim C., Dedieu S., Delacoux F., Hornebeck W., Hinek A., Martiny L., Debelle L. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J. Biol. Chem. 2007, 282:12484-12491.
14. Ebihara T., Venkatesan N., Tanaka R., Ludwig M.S. Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects. Am. J. Respir. Crit. Care Med. 2000, 162:1569-1576.
15. Fernandez Perez E.R., Daniels C.E., Schroeder D.R., Sauver J., Hartman T.E., Bartholmai B.J., Yi E.S., Ryu J.H. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010, 137:129-137.
16. Fichard A., Kleman J.P., Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol. 1995, 14:515-531.
17. Fitch P.M., Howie S.E.M., Wallace W.A.H. Oxidative damage and TGF-β differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease. Int. J. Exp. Pathol. 2011, 92:8-17.
18. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 2007, 127:526-537.
19. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmoulière A., Varga J., De Wever O., Mareel M., Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180:1340-1355.
20. Hoff C.R., Perkins D.R., Davidson J.M. Elastin gene expression is upregulated during pulmonary fibrosis. Connect. Tissue Res. 1999, 40:145-153.
21. Kaarteenaho-Wiik R., Mertaniemi P., Sajanti E., Soini Y., Paakko P. Tenascin is increased in epithelial lining fluid in fibrotic lung disorders. Lung 1998, 176:371-380.
22. Kuhn C., Mason R.J. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am. J. Pathol. 1995, 147:1759-1769.
23. Laurent G.J., McAnulty R.J., Corrin B., Cockerill P. Biochemical and histological changes in pulmonary fibrosis induced in rabbits with intratracheal bleomycin. Eur. J. Clin. Invest. 1981, 11:441-448.
24. Liu F., Mih J.D., Shea B.S., Kho A.T., Sharif A.S., Tager A.M., Tschumperlin D.J. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J. Cell Biol. 2010, 190:693-706.
25. Lucey E.C., Ngo H.Q., Agarwal A., Smith B.D., Snider G.L., Goldstein R.H. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. Lab. Invest. 1996, 74:12-20.
26. Meltzer E.B., Noble P.W. Idiopathic pulmonary fibrosis. Orphanet J. Rare Dis. 2008, 3:8.
27. Moeller A., Ask K., Warburton D., Gauldie J., Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int. J. Biochem. Cell Biol. 2008, 40:362-382.
28. Nalysnyk L., Cid-Ruzafa J., Rotella P., Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur. Respir. Rev. 2012, 21:355-361.
29. Parra E.R., Teodoro W.R., Velosa A.P.P., de Oliveira C.C., Yoshinari N.H., Capelozzi V.L. Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia. J. Histochem. Cytochem. 2006, 54:1315-1325.
30. Peng R., Sridhar S., Tyagi G., Phillips J.E., Garrido R., Harris P., Burns L., Renteria L., Woods J., Chen L., Allard J., Ravindran P., Bitter H., Liang Z., Hogaboam C.M., Kitson C., Budd D.C., Fine J.S., Bauer C.M.T., Stevenson C.S. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease. PLoS One 2013, 8:e59348.
31. Selman M., Thannickal V.J., Pardo A., Zisman D.A., Martinez F.J., Lynch J.P. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004, 64:405-430.
32. Sime P.J., Xing Z., Graham F.L., Csaky K.G., Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest. 1997, 100:768-776.
33. Starcher B.C., Kuhn C., Overton J.E. Increased elastin and collagen content in the lungs of hamsters receiving an intratracheal injection of bleomycin. Am. Rev. Respir. Dis. 1978, 117:299-305.
34. Suki B., Bates J.H. Extracellular matrix mechanics in lung parenchymal diseases. Respir. Physiol. Neurobiol. 2008, 163:33-43.
35. Tarantal A.F., Chen H., Shi T.T., Lu C.-H., Fang A.B., Buckley S., Kolb M., Gauldie J., Warburton D., Shi W. Overexpression of transforming growth factor-beta1 in fetal monkey lung results in prenatal pulmonary fibrosis. Eur. Respir. J. 2010, 36:907-914.
36. Todd N.W., Luzina I.G., Atamas S.P. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair 2012, 5:11.
37. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
38. Trebaul A., Chan E.K., Midwood K.S. Regulation of fibroblast migration by tenascin-C. Biochem. Soc. Trans. 2007, 35:695-697.
39. Zhao Y., Young S.L., McIntosh J.C. Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Am. J. Physiol. 1998, 274:L1049-L1057.